申请人:Boehringer Mannheim G.m.b.H.
公开号:US04017539A1
公开(公告)日:1977-04-12
New biguanide compounds of the formula: ##STR1## wherein A is saturated or unsaturated cycloaliphatic hydrocarbyl, and the physiologically compatible salts thereof; display outstanding anti-diabetic effectiveness in the treatment of diabetes mellitus, without showing the typical side effects of biguanide treatment, viz., lactacidosis.
新的双胍类化合物的化学式为:##STR1## 其中A是饱和或不饱和的环烷基烃基,以及其生理兼容的盐;这些化合物在糖尿病治疗中表现出卓越的抗糖尿病效果,而不显示双胍治疗的典型副作用,即乳酸中毒。